A monoclonal natural human IgM protects axons in the absence of remyelination

about

Treatment with a recombinant human IgM that recognizes PSA-NCAM preserves brain pathology in MOG-induced experimental autoimmune encephalomyelitis.CSF profile in primary progressive multiple sclerosis: Re-exploring the basics.

P2860

Q38922842-83A96161-4560-495D-AE61-C4B641258049 Q41349564-E8026685-2A23-4CE9-804B-1989CC0AE33D

P2860

A monoclonal natural human IgM protects axons in the absence of remyelination

Item

http://www.wikidata.org/entity/Q36851038

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

A monoclonal natural human IgM protects axons in the absence of remyelination

@en

type

Item

label

A monoclonal natural human IgM protects axons in the absence of remyelination

@en

prefLabel

A monoclonal natural human IgM protects axons in the absence of remyelination

@en

P1476

A monoclonal natural human IgM protects axons in the absence of remyelination

@en

P2093

Aleksandar Denic

http://www.w3.org/2001/XMLSchema#string

Arthur E Warrington

http://www.w3.org/2001/XMLSchema#string

Bharath Wootla

http://www.w3.org/2001/XMLSchema#string

Moses Rodriguez

http://www.w3.org/2001/XMLSchema#string

P2860

Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease

Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1

A single dose of neuron-binding human monoclonal antibody improves spontaneous activity in a murine model of demyelination

Invited article: human natural autoantibodies in the treatment of neurologic disease.

Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis

Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.

Sodium channels as molecular targets in multiple sclerosis.

Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.

A human IgM signals axon outgrowth: coupling lipid raft to microtubules.

A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.

P2888

s12974-016-0561-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12974-016-0561-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1012448028

http://www.w3.org/2001/XMLSchema#string

P698

27126523

http://www.w3.org/2001/XMLSchema#string

P932

4850699

http://www.w3.org/2001/XMLSchema#string

A monoclonal natural human IgM protects axons in the absence of remyelination

about

P2860

P2860

A monoclonal natural human IgM protects axons in the absence of remyelination

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932